Mirai Bio
PrivateLast Round
Series A
Sep 26, 2024
Total Funding Raised
$50M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Mirai Bio is a biotechnology company that provides an open, machine intelligence-driven platform for the end-to-end development, delivery, and manufacturing of genetic medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mirai Bio Comparables
Compare Mirai Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mana.bio | 87% | |
| NanoVation Therapeutics | 85% | |
| Acuitas Therapeutics | 79% |
Mirai Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 26, 2024 |
Mirai Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 7, 2026
Open roles increased to 9, 2.1x the trailing average.
- Aug 31, 2026
Open roles increased to 7, 2.3x the trailing average.
Recent news
Latest coverage and updates
- is_developingAug 26, 2026
MiraiBio Group at Hitachi Solutions America, Ltd. is developing model for nucleic acid medicine delivery on Aug 26th '26
- promotesAug 26, 2026
MiraiBio Group at Hitachi Solutions America, Ltd. promoted Jagesh V. Shah to Chief Scientific Officer on Aug 26th '26
- hiresAug 26, 2026
MiraiBio Group at Hitachi Solutions America, Ltd. hired Jeff Luber as Board Chair on Aug 26th '26
- hiresAug 26, 2026
MiraiBio Group at Hitachi Solutions America, Ltd. hired Torchilin as Chief Executive Officer and President of Mirai and CEO-Partner on Aug 26th '26
- hiresAug 26, 2026
MiraiBio Group at Hitachi Solutions America, Ltd. hired Shah as Chief Scientific Officer on Jul 1st '24
Mirai Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access